Sign In
Buy BNTX
$90.58
-2.27 (-2.44%)
At Close: Jul 31, 2026
Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-adapted COVID-19 Vaccine in the European Union
02:30am, Friday, 25'th Jul 2025
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) announced today that the European Medicines Agency's (EMA) Committee fo
Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union
02:30am, Friday, 25'th Jul 2025
NEW YORK and MAINZ, GERMANY, July 25, 2025 — Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) announced today that the European Medicines Agency's (EMA) Committee
Has BioNTech (BNTX) Outpaced Other Medical Stocks This Year?
10:41am, Thursday, 24'th Jul 2025
Here is how BioNTech SE Sponsored ADR (BNTX) and EUROFINS SCIENT (ERFSF) have performed compared to their sector so far this year.
8MM Exanthema Market Report 2025-2034 | Rising Viral Infections and Diagnostic Innovations Across Major Markets Fueling Growth
04:11am, Wednesday, 23'rd Jul 2025
The exanthema market is projected to grow from USD 1.39 billion in 2024 to USD 2.51 billion by 2034 at a CAGR of 6.10%. This growth is driven by rising viral infections and diagnostic innovations acro
BioNTech to Report Second Quarter 2025 Financial Results and Corporate Update on August 4, 2025
06:45am, Monday, 21'st Jul 2025
MAINZ, Germany, July 21, 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the second quarter 2025 on Monday, August 4,
BioNTech Announces Ryan Richardson to Step Down from the Management Board
08:30am, Thursday, 17'th Jul 2025
MAINZ, Germany, July 17, 2025 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today that Ryan Richardson will step down as Chief Strategy Officer in the
Pfizer, BioNTech ask UK court to overturn Moderna's COVID vaccine patent win
07:18am, Thursday, 10'th Jul 2025
Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 vaccine infringed one of Moderna's patents, in the latest round of a long-run
CureVac Stock Soars on BioNTech Buyout
11:08am, Thursday, 12'th Jun 2025
Biotech stock CureVac NV (NASDAQ:CVAC) was last seen up 32.2% at $5.37, after news that BioNTech (BNTX) is acquiring the company in all-stock deal worth $1.25 billion.
BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal
11:07am, Thursday, 12'th Jun 2025
BioNTech SE BNTX on Thursday agreed to acquire CureVac N.V. CVAC in an all-stock transaction.
BioNTech boosts cancer mRNA pipeline with CureVac acquisition
10:34am, Thursday, 12'th Jun 2025
BioNTech (NASDAQ:BNTX) announced that it is acquiring CureVac (NASDAQ:CVAC), a fellow German mRNA vaccine developer, in an all-stock deal valued at approximately $1.25 billion. Under the deal terms,
BioNTech to Buy CureVac in $1.25 Billion Deal. Both Stocks Are Rising.
07:11am, Thursday, 12'th Jun 2025
CureVac stock soared 29% $5.26 in premarket trading immediately following the news.
BioNTech to acquire CureVac in $1.25 billion all-stock deal
07:03am, Thursday, 12'th Jun 2025
German biotech firm BioNTech said on Thursday it agreed to acquire domestic peer CureVac for about $1.25 billion worth of BioNTech shares to boost its work on new mRNA-based cancer treatments.
BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer
06:45am, Thursday, 12'th Jun 2025
MAINZ and TÜBINGEN, Germany, June 12, 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech”) and CureVac N.V. (Nasdaq: CVAC, “CureVac”) today announced that they have entered into
RFK Jr.'s firing of CDC vaccine advisors 'circumvents science' and could threaten public health, experts say
11:50am, Tuesday, 10'th Jun 2025
Health and Human Services Secretary Robert F. Kennedy Jr. has gutted a key government panel of vaccine advisors, a stunning move that some public health experts say undermines science, disrupts a trus
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
09:30am, Tuesday, 10'th Jun 2025
Shares of global vaccine makers were muted on Tuesday as investors and analysts took a "wait and watch" approach after U.S. Health Secretary Robert F. Kennedy Jr. fired all members of an expert vaccin
